Carbazochrome

Carbazochrome (CAS No.: 69-81-8) is an important antihemorrhagic agent used in biomedical research, mainly applied in the fields of capillary stability and bleeding research. As a hemostatic agent, it effectively stops blood flow by promoting platelet aggregation and adhesion to form platelet clots. In in vitro studies, this compound has shown the ability to reverse barrier dysfunction induced by trypsin, thrombin, and bradykinin, while not affecting endothelial permeability enhanced by calcium ionophores. Experiments have shown that Carbazochrome, when used at a dose of 0.1 mg/kg in a mouse traumatic bleeding model, can effectively reduce bleeding by 45%. In addition, topical application has also demonstrated the effect of enhancing coagulation at wound sites in mice. Researchers often use different concentrations and models to explore its mechanistic pathways, including actin stress fiber formation and VE-cadherin disruption in porcine aortic endothelial cells. Although its role as an antihemorrhagic agent has been well documented, further research is still needed to fully understand its efficacy and potential side effects, thereby optimizing its application in drug discovery and development research.